These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 25501296)

  • 21. Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update.
    Joshi R; Kulkarni YA; Wairkar S
    Life Sci; 2018 Dec; 215():43-56. PubMed ID: 30391464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmacological and biological roles of eriodictyol.
    Islam A; Islam MS; Rahman MK; Uddin MN; Akanda MR
    Arch Pharm Res; 2020 Jun; 43(6):582-592. PubMed ID: 32594426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compendium of naringenin: potential sources, analytical aspects, chemistry, nutraceutical potentials and pharmacological profile.
    Singh S; Sharma A; Monga V; Bhatia R
    Crit Rev Food Sci Nutr; 2023; 63(27):8868-8899. PubMed ID: 35357240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flavanones inhibit the clonogenicity of HCT116 cololectal cancer cells.
    Woo Y; Shin SY; Hyun J; Lee SD; Lee YH; Lim Y
    Int J Mol Med; 2012 Mar; 29(3):403-8. PubMed ID: 22160193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient synthesis of polyoxygenated flavones from naturally occurring flavanones.
    Bovicelli P; D'Angelo V; Collalto D; Verzina A; D'Antona N; Lambusta D
    J Pharm Pharmacol; 2007 Dec; 59(12):1697-701. PubMed ID: 18053332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Compressive Review on Source, Toxicity and Biological Activity of Flavonoid.
    Singh B; Semwal BC
    Curr Top Med Chem; 2024; 24(24):2093-2116. PubMed ID: 39108008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of apoptosis by modified naringenin derivatives in human colorectal carcinoma RKO cells.
    Lee ER; Kang YJ; Kim HJ; Choi HY; Kang GH; Kim JH; Kim BW; Jeong HS; Park YS; Cho SG
    J Cell Biochem; 2008 May; 104(1):259-73. PubMed ID: 18004724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flavonoid Myricetin as Potent Anticancer Agent: A Possibility towards Development of Potential Anticancer Nutraceuticals.
    Trivedi A; Hasan A; Ahmad R; Siddiqui S; Srivastava A; Misra A; Mir SS
    Chin J Integr Med; 2024 Jan; 30(1):75-84. PubMed ID: 37340205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flavonoids as Anticancer Agents.
    Kopustinskiene DM; Jakstas V; Savickas A; Bernatoniene J
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32059369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
    Baldisserotto A; Vertuani S; Bino A; De Lucia D; Lampronti I; Milani R; Gambari R; Manfredini S
    Bioorg Med Chem; 2015 Jan; 23(1):264-71. PubMed ID: 25496805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SAR and QSAR of the antioxidant activity of flavonoids.
    Amić D; Davidović-Amić D; Beslo D; Rastija V; Lucić B; Trinajstić N
    Curr Med Chem; 2007; 14(7):827-45. PubMed ID: 17346166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary Flavonoids: Cardioprotective Potential with Antioxidant Effects and Their Pharmacokinetic, Toxicological and Therapeutic Concerns.
    Khan J; Deb PK; Priya S; Medina KD; Devi R; Walode SG; Rudrapal M
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34209338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural activity relationship of flavonoids with estrogen-related receptor gamma.
    Huang Z; Fang F; Wang J; Wong CW
    FEBS Lett; 2010 Jan; 584(1):22-6. PubMed ID: 19914244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanisms of flavonoids in myocardial ischemia reperfusion injury: Evidence from in-vitro and in-vivo studies.
    Sharma J; Bhargava P; Mishra P; Bhatia J; Arya DS
    Vascul Pharmacol; 2024 Jun; 155():107378. PubMed ID: 38729253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flavonoids as Natural Anti-Inflammatory Agents Targeting Nuclear Factor-Kappa B (NFκB) Signaling in Cardiovascular Diseases: A Mini Review.
    Choy KW; Murugan D; Leong XF; Abas R; Alias A; Mustafa MR
    Front Pharmacol; 2019; 10():1295. PubMed ID: 31749703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naringenin: A potential flavonoid phytochemical for cancer therapy.
    Motallebi M; Bhia M; Rajani HF; Bhia I; Tabarraei H; Mohammadkhani N; Pereira-Silva M; Kasaii MS; Nouri-Majd S; Mueller AL; Veiga FJB; Paiva-Santos AC; Shakibaei M
    Life Sci; 2022 Sep; 305():120752. PubMed ID: 35779626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DFT Studies on the Antioxidant Activity of Naringenin and Its Derivatives: Effects of the Substituents at C3.
    Zheng YZ; Deng G; Guo R; Chen DF; Fu ZM
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combating oxidative stress disorders with citrus flavonoid: Naringenin.
    Zaidun NH; Thent ZC; Latiff AA
    Life Sci; 2018 Sep; 208():111-122. PubMed ID: 30021118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical changes and antioxidant capacity of naringin and naringenin against malathion toxicity in Saccharomyces cerevisiae.
    Gerçek E; Zengin H; Erdem Erişir F; Yılmaz Ö
    Comp Biochem Physiol C Toxicol Pharmacol; 2021 Mar; 241():108969. PubMed ID: 33412300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pharmacological perspective on the use of Brazilian Red Propolis and its isolated compounds against human diseases.
    Freires IA; de Alencar SM; Rosalen PL
    Eur J Med Chem; 2016 Mar; 110():267-79. PubMed ID: 26840367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.